BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26704433)

  • 21. Phase II escalation study of sorafenib in patients with metastatic renal cell carcinoma who have been previously treated with anti-angiogenic treatment.
    Mancuso A; Di Paola ED; Leone A; Catalano A; Calabrò F; Cerbone L; Zivi A; Messina C; Alonso S; Vigna L; Caristo R; Sternberg CN
    BJU Int; 2012 Jan; 109(2):200-6. PubMed ID: 22212284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human chorionic gonadotrophin producing epithelioid sarcoma metastatic to the placenta.
    Steffensen TS; Gilbert-Barness E; Wagoner MJ; Bui MM; Browarsky IL
    Fetal Pediatr Pathol; 2008; 27(6):282-91. PubMed ID: 19065326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human chorionic gonadotropin exhibits normal biological activity in patients with recurrent pregnancy loss.
    Kato K; Mostafa MH; Mann K; Schindler AE; Hoermann R
    Gynecol Endocrinol; 2002 Jun; 16(3):179-86. PubMed ID: 12192889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of C-reactive protein kinetics on survival of patients with metastatic renal cell carcinoma.
    Saito K; Tatokoro M; Fujii Y; Iimura Y; Koga F; Kawakami S; Kihara K
    Eur Urol; 2009 May; 55(5):1145-53. PubMed ID: 18930583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of myeloid-derived suppressor cells and efficacy of cytokine-induced killer cell immunotherapy in metastatic renal cell carcinoma patients.
    Wang Z; Zhang Y; Liu Y; Wang L; Zhao L; Yang T; He C; Song Y; Gao Q
    J Immunother; 2014 Jan; 37(1):43-50. PubMed ID: 24316555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of renal cell carcinoma in pregnancy: simultaneous nephron-sparing surgery and Caesarian section (case report).
    Pertia A; Gagua D; Managadze L; Chkhotua A
    Georgian Med News; 2011 Dec; (201):7-10. PubMed ID: 22306491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metastatic renal cell cancer in a 20-year-old pregnant woman.
    van der Veldt AA; van Wouwe M; van den Eertwegh AJ; van Moorselaar RJ; van Geijn HP
    Urology; 2008 Oct; 72(4):775; discussion 776-7. PubMed ID: 18723209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid growth of an ovarian clear cell carcinoma expressing LH/hCG receptor arising from endometriosis during early pregnancy.
    Kobayashi F; Monma C; Nanbu K; Konishi I; Sagawa N; Mori T
    Gynecol Oncol; 1996 Aug; 62(2):309-13. PubMed ID: 8751567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lumbar metastasis of choriocarcinoma.
    Naito Y; Akeda K; Kasai Y; Matsumine A; Tabata T; Nagao K; Uchida A
    Spine (Phila Pa 1976); 2009 Jul; 34(15):E538-43. PubMed ID: 19564760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient-based strategy for systemic treatment of metastatic renal cell carcinoma.
    Kirchner H; Strumberg D; Bahl A; Overkamp F
    Expert Rev Anticancer Ther; 2010 Apr; 10(4):585-96. PubMed ID: 20397923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
    Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
    Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contemporary trends in high-dose interleukin-2 use for metastatic renal cell carcinoma in the United States.
    Allard CB; Gelpi-Hammerschmidt F; Harshman LC; Choueiri TK; Faiena I; Modi P; Chung BI; Tinay I; Singer EA; Chang SL
    Urol Oncol; 2015 Nov; 33(11):496.e11-6. PubMed ID: 26210683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of patients with metastatic renal cell carcinoma after failure of first-line treatment.
    Carles J; Chirivella I; Climent MA; Gallardo E; González del Alba A; Maroto JP; Mellado B; García del Muro FX
    Cancer Metastasis Rev; 2012 Sep; 31 Suppl 1():S3-9. PubMed ID: 22689342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic contrast-enhanced magnetic resonance imaging in the early evaluation of anti-angiogenic therapy in metastatic renal cell carcinoma.
    Panebianco V; Iacovelli R; Barchetti F; Altavilla A; Forte V; Sciarra A; Cortesi E; Catalano C
    Anticancer Res; 2013 Dec; 33(12):5663-6. PubMed ID: 24324114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human chorionic gonadotropin in maternal plasma after induced abortion, spontaneous abortion, and removed ectopic pregnancy.
    Steier JA; Bergsjø P; Myking OL
    Obstet Gynecol; 1984 Sep; 64(3):391-4. PubMed ID: 6462569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.
    Heng DY; Wells JC; Rini BI; Beuselinck B; Lee JL; Knox JJ; Bjarnason GA; Pal SK; Kollmannsberger CK; Yuasa T; Srinivas S; Donskov F; Bamias A; Wood LA; Ernst DS; Agarwal N; Vaishampayan UN; Rha SY; Kim JJ; Choueiri TK
    Eur Urol; 2014 Oct; 66(4):704-10. PubMed ID: 24931622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbonic anhydrase IX expression is associated with improved outcome of high-dose interleukin-2 therapy for metastatic renal cell carcinoma.
    Dudek AZ; Yee RT; Manivel JC; Isaksson R; Yee HO
    Anticancer Res; 2010 Mar; 30(3):987-92. PubMed ID: 20393025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term follow-up of patients with metastatic renal cell carcinoma treated with intravenous recombinant interleukin-2 in Europe.
    Negrier S; Maral J; Drevon M; Vinke J; Escudier B; Philip T
    Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S93-8. PubMed ID: 10685667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complete remission achieved with angiogenic therapy in metastatic renal cell carcinoma including surgical intervention.
    Staehler M; Haseke N; Zilinberg E; Stadler T; Karl A; Siebels M; Dürr HR; Siegert S; Jauch KW; Bruns CJ; Stief CG
    Urol Oncol; 2010; 28(2):139-44. PubMed ID: 19576802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors and model for predicting toxicity-related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
    Kaymakcalan MD; Xie W; Albiges L; North SA; Kollmannsberger CK; Smoragiewicz M; Kroeger N; Wells JC; Rha SY; Lee JL; McKay RR; Fay AP; De Velasco G; Heng DY; Choueiri TK
    Cancer; 2016 Feb; 122(3):411-9. PubMed ID: 26540173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.